The EIR was issued with an inspection classification of Voluntary Action Indicated (VAI) post the inspection of the facility from September 16 to September 27, 2024
Services like 24/7 Ayush Multi-OPD clinics, mobile healthcare units, free distribution of Ayush medicines, and yoga camps are there for all visitors
Increases speed to market for drug developers working on nucleic acid therapeutics
Acquisition expands high-value medical platform
Successfully transformed the organization from a two-country operation focused on development and manufacturing to a fully integrated company with a strong commercial engine bringing us closer to patients in over 120 countries
These initiatives will strengthen the company’s capital base, providing financial flexibility for future
The inspection, which is a routine part of the FDA's regulatory oversight, evaluates compliance with Good Manufacturing Practices and other regulatory requirements.
Consequent to this appointment, Sarosh Shetty ceases to be Interim CEO of ICH.
The cornerstone of the quality ecosystem is the implementation of the Quality Control Orders
The biosimilar Ustekinumab has been developed and manufactured by the company
Subscribe To Our Newsletter & Stay Updated
